Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate

Charmi Patel; Bruno Emond; Marie-Hélène Lafeuille; Aurélie Côté-Sergent; Patrick Lefebvre; Neeta Tandon; Antoine C. El Khoury

doi:10.1007/s40801-019-00172-9

Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate

Drugs - Real World Outcomes ◽

10.1007/s40801-019-00172-9 ◽

2019 ◽

Vol 7 (1) ◽

pp. 19-29

Author(s):

Charmi Patel ◽

Bruno Emond ◽

Marie-Hélène Lafeuille ◽

Aurélie Côté-Sergent ◽

Patrick Lefebvre ◽

...

Keyword(s):

Real World ◽

Paliperidone Palmitate ◽

Oral Risperidone

Download Full-text

Transitioning from oral risperidone or paliperidone to once-monthly paliperidone palmitate: a real-world analysis among Veterans Health Administration patients with schizophrenia who have had at least one prior hospitalization

Current Medical Research and Opinion ◽

10.1080/03007995.2019.1651129 ◽

2019 ◽

Vol 35 (12) ◽

pp. 2159-2168

Author(s):

Antoine El Khoury ◽

Charmi Patel ◽

Ahong Huang ◽

Li Wang ◽

Richa Bashyal

Keyword(s):

Real World ◽

Veterans Health Administration ◽

Paliperidone Palmitate ◽

Veterans Health ◽

Health Administration ◽

Oral Risperidone

Download Full-text

Clinical effectiveness of early treatment with paliperidone palmitate in schizophrenia: A retrospective real‐world study in South Korea

Early Intervention in Psychiatry ◽

10.1111/eip.13116 ◽

2021 ◽

Author(s):

Wonsuk Shin ◽

Dong Hyeon Lee ◽

Min‐Kyoung Kim ◽

Sang‐Hyuk Lee ◽

Doo‐Yeoun Cho ◽

...

Keyword(s):

South Korea ◽

Real World ◽

Early Treatment ◽

Clinical Effectiveness ◽

Paliperidone Palmitate

Download Full-text

Real-world data on paliperidone palmitate for the treatment of schizophrenia and other psychotic disorders

International Clinical Psychopharmacology ◽

10.1097/yic.0000000000000195 ◽

2018 ◽

Vol 33 (1) ◽

pp. 15-33 ◽

Cited By ~ 5

Author(s):

Robin Emsley ◽

Eduard Parellada ◽

Miquel Bioque ◽

Berta Herrera ◽

Teresa Hernando ◽

...

Keyword(s):

Real World ◽

Psychotic Disorders ◽

Paliperidone Palmitate ◽

Real World Data ◽

World Data

Download Full-text

Evaluating the cost and clinical effectiveness of long-acting, injectable aripiprazole and paliperidone palmitate once a month in a real-world setting

ClinicoEconomics and Outcomes Research ◽

10.2147/ceor.s191198 ◽

2019 ◽

Vol Volume 11 ◽

pp. 517-524

Author(s):

Richard E Hodgson

Keyword(s):

Real World ◽

Clinical Effectiveness ◽

Paliperidone Palmitate ◽

Real World Setting ◽

Long Acting ◽

The Cost

Download Full-text

Baseline characteristics and treatment patterns of patients with schizophrenia initiated on once-every-three-months paliperidone palmitate in a real-world setting

Current Medical Research and Opinion ◽

10.1080/03007995.2017.1359516 ◽

2017 ◽

Vol 33 (10) ◽

pp. 1763-1772 ◽

Cited By ~ 8

Author(s):

Kruti Joshi ◽

Marie-Hélène Lafeuille ◽

Brianne Brown ◽

Willy Wynant ◽

Bruno Emond ◽

...

Keyword(s):

Real World ◽

Treatment Patterns ◽

Paliperidone Palmitate ◽

Real World Setting ◽

Baseline Characteristics

Download Full-text

“Real world” clinical effectiveness of paliperidone palmitate 3-monthly injectable in early psychosis patients

Psychopharmacology ◽

10.1007/s00213-020-05656-z ◽

2020 ◽

Vol 237 (12) ◽

pp. 3795-3797

Author(s):

Vincent Ferraro ◽

Simon Lafrenière ◽

Marie-France Demers ◽

Marc-André Roy ◽

Amal Abdel-Baki

Keyword(s):

Real World ◽

Clinical Effectiveness ◽

Early Psychosis ◽

Paliperidone Palmitate

Download Full-text

Anaphylactoid reaction to paliperidone palmitate extended-release injectable suspension in a patient tolerant of oral risperidone

American Journal of Health-System Pharmacy ◽

10.2146/ajhp110230 ◽

2012 ◽

Vol 69 (1) ◽

pp. 40-43 ◽

Cited By ~ 2

Author(s):

Richard Perry ◽

James Wolberg ◽

Steven DiCrescento

Keyword(s):

Extended Release ◽

Anaphylactoid Reaction ◽

Paliperidone Palmitate ◽

Oral Risperidone

Download Full-text

Real-world evidence of improved healthcare utilization in patients with schizophrenia or schizoaffective disorder after early treatment of paliperidone palmitate once-monthly treatment in Hong Kong

Journal of Medical Economics ◽

10.1080/13696998.2018.1560749 ◽

2019 ◽

Vol 22 (3) ◽

pp. 273-279 ◽

Cited By ~ 2

Author(s):

June W. Y. Choon ◽

David B. C. Wu ◽

H. Y. Chong ◽

William T. L. Lo ◽

Catherine S. Y. Chong ◽

...

Keyword(s):

Hong Kong ◽

Healthcare Utilization ◽

Real World ◽

Schizoaffective Disorder ◽

Early Treatment ◽

Paliperidone Palmitate ◽

Real World Evidence

Download Full-text

P.848Functionality in patients with newly diagnosed schizophrenia treated with paliperidone palmitate 3-month formulation in real-world clinical practice study (TIME study)

European Neuropsychopharmacology ◽

10.1016/j.euroneuro.2020.09.611 ◽

2020 ◽

Vol 40 ◽

pp. S470-S471

Author(s):

M.P. García-Portilla ◽

F. Gómez ◽

A. Benito ◽

P. Lopez ◽

M. Garcia

Keyword(s):

Clinical Practice ◽

Real World ◽

Study Time ◽

Paliperidone Palmitate ◽

Time Study ◽

Newly Diagnosed ◽

Practice Study

Download Full-text

Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia

International Clinical Psychopharmacology ◽

10.1097/yic.0000000000000006 ◽

2014 ◽

Vol 29 (1) ◽

pp. 45-55 ◽

Cited By ~ 17

Author(s):

Dong-Jing Fu ◽

Cynthia A. Bossie ◽

Jennifer K. Sliwa ◽

Yi-Wen Ma ◽

Larry Alphs

Keyword(s):

Paliperidone Palmitate ◽

Oral Risperidone ◽

Long Acting

Download Full-text